Drug Profile
NT 2 - Nanotargeting
Alternative Names: NT2 - NanotargetingLatest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Nanotargeting
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Cancer in Spain (Parenteral)
- 18 Jul 2016 Early research in Cancer in Spain (Parenteral)